186 related articles for article (PubMed ID: 34050678)
1. Prenatal histological, cellular, and molecular anomalies in trisomy 21 lung.
Danopoulos S; Bhattacharya S; Deutsch G; Nih LR; Slaunwhite C; Mariani TJ; Al Alam D
J Pathol; 2021 Sep; 255(1):41-51. PubMed ID: 34050678
[TBL] [Abstract][Full Text] [Related]
2. A Trisomy 21 Lung Cell Atlas.
Bhattacharya S; Cherry C; Deutsch G; ; Glass IA; Mariani TJ; Alam DA; Danopoulos S
bioRxiv; 2023 Apr; ():. PubMed ID: 37066313
[TBL] [Abstract][Full Text] [Related]
3. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.
Guedj F; Siegel AE; Pennings JLA; Alsebaa F; Massingham LJ; Tantravahi U; Bianchi DW
Am J Hum Genet; 2020 Nov; 107(5):911-931. PubMed ID: 33098770
[TBL] [Abstract][Full Text] [Related]
4. Two-stage approach for risk estimation of fetal trisomy 21 and other aneuploidies using computational intelligence systems.
Neocleous AC; Syngelaki A; Nicolaides KH; Schizas CN
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):503-508. PubMed ID: 28640401
[TBL] [Abstract][Full Text] [Related]
5. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
[TBL] [Abstract][Full Text] [Related]
6. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine death in singleton pregnancies with trisomy 21, 18, 13 and monosomy X.
Goulart VV; Liao AW; Carvalho MH; Brizot Mde L; Francisco RP; Zugaib M
Rev Assoc Med Bras (1992); 2016 Apr; 62(2):162-70. PubMed ID: 27167547
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.
Sullivan KD; Evans D; Pandey A; Hraha TH; Smith KP; Markham N; Rachubinski AL; Wolter-Warmerdam K; Hickey F; Espinosa JM; Blumenthal T
Sci Rep; 2017 Nov; 7(1):14818. PubMed ID: 29093484
[TBL] [Abstract][Full Text] [Related]
9. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21.
Lim JH; Lee DE; Park SY; Kim DJ; Ahn HK; Han YJ; Kim MY; Ryu HM
BMC Med Genomics; 2014 Jan; 7():1. PubMed ID: 24397966
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide gene expression analysis in the placenta from fetus with trisomy 21.
Lim JH; Han YJ; Kim HJ; Kwak DW; Park SY; Chun SH; Ryu HM
BMC Genomics; 2017 Sep; 18(1):720. PubMed ID: 28899343
[TBL] [Abstract][Full Text] [Related]
11. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy.
Mao J; Wang T; Wang BJ; Liu YH; Li H; Zhang J; Cram D; Chen Y
Clin Chim Acta; 2014 Jun; 433():190-3. PubMed ID: 24667696
[TBL] [Abstract][Full Text] [Related]
12. The transcriptome profile of human trisomy 21 blood cells.
Antonaros F; Zenatelli R; Guerri G; Bertelli M; Locatelli C; Vione B; Catapano F; Gori A; Vitale L; Pelleri MC; Ramacieri G; Cocchi G; Strippoli P; Caracausi M; Piovesan A
Hum Genomics; 2021 May; 15(1):25. PubMed ID: 33933170
[TBL] [Abstract][Full Text] [Related]
13. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
[TBL] [Abstract][Full Text] [Related]
14. DNA-Methylation Patterns in Trisomy 21 Using Cells from Monozygotic Twins.
Sailani MR; Santoni FA; Letourneau A; Borel C; Makrythanasis P; Hibaoui Y; Popadin K; Bonilla X; Guipponi M; Gehrig C; Vannier A; Carre-Pigeon F; Feki A; Nizetic D; Antonarakis SE
PLoS One; 2015; 10(8):e0135555. PubMed ID: 26317209
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
Lindquist A; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
[TBL] [Abstract][Full Text] [Related]
16. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density.
Lim JH; Lee DE; Kim KS; Kim HJ; Lee BY; Park SY; Ahn HK; Lee SW; Kim MY; Ryu HM
Clin Chem Lab Med; 2014 May; 52(5):641-7. PubMed ID: 24353143
[TBL] [Abstract][Full Text] [Related]
18. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
[TBL] [Abstract][Full Text] [Related]
19. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
[TBL] [Abstract][Full Text] [Related]
20. Impact of prenatal screening on the prevalence of Down syndrome in Slovenia.
Rudolf G; Tul N; Verdenik I; Volk M; Brezigar A; Kokalj Vokač N; Jeršin N; Prosenc B; Premru Sršen T; Peterlin B
PLoS One; 2017; 12(6):e0180348. PubMed ID: 28665986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
